Literature DB >> 31844153

RETRACTED ARTICLE: Inhibition of miR-296-5p protects the heart from cardiac hypertrophy by targeting CACNG6.

Wei Wang1, Nian Liu1, Li Xin1, Yanfei Ruan1, Xin Du1, Rong Bai1, Jianzeng Dong1, ChangSheng Ma2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31844153      PMCID: PMC8221998          DOI: 10.1038/s41434-019-0109-0

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   4.184


× No keyword cloud information.
The Editor-in-Chief has retracted this article [1] due to concerns regarding the figures and the underlying data. The authors informed the journal that they have not been able to reproduce the results presented in the article. Further investigation found significant text overlap with an article by different authors that was simultaneously under consideration at the same time at another journal [2]. Additionally, there appear to be overlapping figures between the two articles: The bottom left two panels of Figure 4F of [1] appear to be identical to the bottom left and bottom right panels of Figure 2B of [2] The TAC panel in Figure 4G of [1] TAC image appears to be a reflection (y axis) of the TAC+control in Figure 4G of [1]. The data reported in this article are therefore unreliable Changsheng Ma agrees to this retraction. The other authors have not responded to correspondence regarding this retraction. The online version of this article contains the full text of the retracted article as electronic supplementary material. Former article version
  2 in total

1.  RETRACTED ARTICLE: Inhibition of miR-296-5p protects the heart from cardiac hypertrophy by targeting CACNG6.

Authors:  Wei Wang; Nian Liu; Li Xin; Yanfei Ruan; Xin Du; Rong Bai; Jianzeng Dong; ChangSheng Ma
Journal:  Gene Ther       Date:  2019-12-16       Impact factor: 4.184

2.  LncRNA AK045171 protects the heart from cardiac hypertrophy by regulating the SP1/MG53 signalling pathway.

Authors:  Li Xu; Hongjiang Wang; Feng Jiang; Hao Sun; Dapeng Zhang
Journal:  Aging (Albany NY)       Date:  2020-02-21       Impact factor: 5.682

  2 in total
  2 in total

1.  RETRACTED ARTICLE: Inhibition of miR-296-5p protects the heart from cardiac hypertrophy by targeting CACNG6.

Authors:  Wei Wang; Nian Liu; Li Xin; Yanfei Ruan; Xin Du; Rong Bai; Jianzeng Dong; ChangSheng Ma
Journal:  Gene Ther       Date:  2019-12-16       Impact factor: 4.184

2.  Empagliflozin prevents doxorubicin-induced myocardial dysfunction.

Authors:  Jolanda Sabatino; Salvatore De Rosa; Laura Tammè; Claudio Iaconetti; Sabato Sorrentino; Alberto Polimeni; Chiara Mignogna; Andrea Amorosi; Carmen Spaccarotella; Masakazu Yasuda; Ciro Indolfi
Journal:  Cardiovasc Diabetol       Date:  2020-05-15       Impact factor: 9.951

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.